Related Experiment Videos
Moyamoya disease: a review.
1Department of Pediatric Neurology, NYU School of Medicine, New York, 10016, USA. Jay2world@aol.com
Neurology India
|April 18, 2002
Summary
Moyamoya disease, an inherited vasocclusive condition, is increasingly understood through genetic and pathogenesis research. Advances in surgical outcomes assessment using functional MRI and PET scanning are improving patient care.
Area of Science:
- Neurology
- Genetics
- Vascular Biology
Background:
- Moyamoya disease is a rare, inherited vasocclusive disorder with a global prevalence, initially identified in Japan.
- Understanding its pathogenesis is evolving, with potential variations across different racial groups.
- Current treatment strategies, particularly revascularization surgery, face ongoing debate regarding optimal timing and methods.
Purpose of the Study:
- To review recent advancements in the genetics and pathogenesis of Moyamoya disease.
- To discuss clinical manifestations and the role of surgical interventions.
- To highlight the need for broader research beyond East Asia.
Main Methods:
- Review of current literature on Moyamoya disease genetics and pathogenesis.
- Analysis of clinical presentations and surgical outcomes.
- Evaluation of advanced imaging techniques (fMRI, PET) and neuropsychological studies for assessing surgical efficacy.
Main Results:
- Genetic linkage studies and pathogenesis research are providing new insights into Moyamoya disease.
- Functional MRI and PET scanning offer objective criteria for evaluating surgical outcomes.
- Neuropsychological assessments can aid in judging the benefits of surgical interventions.
Conclusions:
- Continued research into Moyamoya disease genetics and pathogenesis is crucial for a comprehensive understanding.
- Objective assessment tools like fMRI and PET are vital for evaluating surgical success.
- Expanding research beyond Japan and the Korean peninsula is necessary to fully grasp the disease's global impact and variations.